Schroder Investment Management Group’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.22M | Sell |
420,512
-172,512
| -29% | -$2.55M | 0.01% | 732 |
|
|
2025
Q1 | $11.7M | Buy |
593,024
+175,771
| +42% | +$3.46M | 0.01% | 612 |
|
|
2024
Q4 | $7.23M | Sell |
417,253
-260,199
| -38% | -$4.51M | 0.01% | 706 |
|
|
2024
Q3 | $9.49M | Buy |
677,452
+43,051
| +7% | +$603K | 0.01% | 671 |
|
|
2024
Q2 | $5.21M | Buy |
634,401
+530,024
| +508% | +$4.36M | 0.01% | 774 |
|
|
2024
Q1 | $805K | Buy |
+104,377
| New | +$805K | ﹤0.01% | 1055 |
|